Following its $8.9 million Series B capital raise in March, Okyanos Heart Institute is rapidly approaching the day when it will be able to treat the first heart patient using autologous adipose derived regenerative cells (ADRCs) in the Bahamas. Adipose, or fat, is the richest source of regenerative cells in the body and the term "autologous" simply means that the cells are derived from the same patient undergoing the cell therapy treatment.
Ray Xerri
Breaking News
Subscribe to VCpost newsletter
Most Popular
- Walmart Is Laying off Hundreds of Employees, Asking Remote Workers to Move to Offices
- Social Security Expansion Could Allow Food Stamp Recipients to Automatically Qualify for SSI Benefits
- Chinese Companies Dominate Licensing Bids to Explore Iraq Oil and Gas Fields as US Snubs Energy Bidding Round
- Elon Musk Slams Mark Zuckerberg's Meta for Engaging in 'Super Greedy' Advertising Practices
- SNAP Benefits 2024: Storm-Affected Residents to Receive Replacement Applications, Extended Deadline
- Elon Musk Rehires Tesla Supercharger Team Weeks After Getting Slashed
- Corporate Greed Is Not the Main Driver of US Inflation: Fed Study
- Homeless Woman Discovered Living Inside Michigan Grocery Store Signage With Computer, Coffee Maker After Contractors Found Suspicious Extension Cord